Patent: 5,028,439
✉ Email this page to a colleague
Summary for Patent: 5,028,439
Title: | Inhibition of parathyroid hormone secretion |
Abstract: | Parathyroid Hormone, when excessively synthesized, induces pathologic bone resorption and demineralization and results in hypocalcemia which produces toxic effects in soft tissues. Non-toxic water-soluble pharmaceutically acceptable compound derivative of peroxydiphosphoric acid, administered orally or systemically, inhibits parathyroid hormone induced bone resorption in vitro and in vivo in warm blooded animals. |
Inventor(s): | Gaffar; Abdul (Somerset, NJ) |
Assignee: | Colgate Palmolive Company (Piscataway, NJ) |
Application Number: | 07/296,390 |
Patent Claims: | see list of patent claims |
Details for Patent 5,028,439
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Takeda Pharmaceuticals U.s.a., Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | January 23, 2015 | ⤷ Sign Up | 2008-07-02 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |